BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22736202)

  • 1. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
    Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
    Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
    Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
    Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
    PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
    Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
    Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-regulated kinase/matrix metalloproteinase-9 axis.
    Jia YL; Shi L; Zhou JN; Fu CJ; Chen L; Yuan HF; Wang YF; Yan XL; Xu YC; Zeng Q; Yue W; Pei XT
    Hepatology; 2011 Nov; 54(5):1808-18. PubMed ID: 22045676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
    Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
    Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
    Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
    Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch1 signaling pathway participates in cancer invasion by regulating MMPs in lingual squamous cell carcinoma.
    Yu B; Wei J; Qian X; Lei D; Ma Q; Liu Y
    Oncol Rep; 2012 Feb; 27(2):547-52. PubMed ID: 21993452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
    Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
    Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Cui L; Gao B; Cao Z; Chen X; Zhang S; Zhang W
    Mol Med Rep; 2016 Mar; 13(3):2032-8. PubMed ID: 26781180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
    BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.
    Hsieh MJ; Lin CW; Yang SF; Chen MK; Chiou HL
    Br J Pharmacol; 2014 Jun; 171(12):3037-50. PubMed ID: 24641665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.